CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on engineering herpes simplex viruses to selectively target and kill cancer cells while sparing normal cells. It aims to improve cancer treatment efficacy and safety through genetic modifications of the virus.
Cancer remains a major health burden worldwide.
The aggressive targeting of metabolic pathways shared by normal and cancer cells results in prolonged survival and cures, but at a tremendous cost to patient life quality.
What is missing is a therapeutic agent that clearly differentiates normal and cancer cells.
This proposal delineates a process for killing exclusively cancer cells with no interference with normal cells.
In the past two decades there has been considerable effort to develop attenu…
ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
